These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21610224)

  • 1. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case-control studies.
    Louie KS; Castellsague X; de Sanjose S; Herrero R; Meijer CJ; Shah K; Munoz N; Bosch FX;
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1379-90. PubMed ID: 21610224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.
    Castellsagué X; Bosch FX; Muñoz N; Meijer CJ; Shah KV; de Sanjose S; Eluf-Neto J; Ngelangel CA; Chichareon S; Smith JS; Herrero R; Moreno V; Franceschi S;
    N Engl J Med; 2002 Apr; 346(15):1105-12. PubMed ID: 11948269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development.
    Gunnell AS; Tran TN; Torrång A; Dickman PW; Sparén P; Palmgren J; Ylitalo N
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2141-7. PubMed ID: 17057029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.
    Vaccarella S; Herrero R; Snijders PJ; Dai M; Thomas JO; Hieu NT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Muñoz N; Meijer CJ; Franceschi S;
    Int J Epidemiol; 2008 Jun; 37(3):536-46. PubMed ID: 18316350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
    Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
    Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
    Kapeu AS; Luostarinen T; Jellum E; Dillner J; Hakama M; Koskela P; Lenner P; Löve A; Mahlamaki E; Thoresen S; Tryggvadóttir L; Wadell G; Youngman L; Lehtinen M
    Am J Epidemiol; 2009 Feb; 169(4):480-8. PubMed ID: 19074773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study.
    Plummer M; Herrero R; Franceschi S; Meijer CJ; Snijders P; Bosch FX; de Sanjosé S; Muñoz N;
    Cancer Causes Control; 2003 Nov; 14(9):805-14. PubMed ID: 14682438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
    Castellsagué X; Muñoz N
    J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1043-9. PubMed ID: 11045786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
    Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S;
    Lancet; 2002 Mar; 359(9312):1085-92. PubMed ID: 11943255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between cervical carcinogenesis and tobacco use by sexual partners.
    Siokos AG; Siokou-Siova O; Tzafetas I
    Hell J Nucl Med; 2019; 22 Suppl 2():184-190. PubMed ID: 31802062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India.
    Sobti RC; Kaur S; Kaur P; Singh J; Gupta I; Jain V; Nakahara A
    Cancer Genet Cytogenet; 2006 Apr; 166(2):117-23. PubMed ID: 16631467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of Passive Smoking as a Risk Factor of High-Grade Squamous Intraepithelial Lesion: A Case-Control Study.
    Du X; Li M; Zhou Y; Yang H; Isachenko V; Takagi T; Meng Y
    Biol Pharm Bull; 2020; 43(7):1061-1066. PubMed ID: 32612068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.